Mesoporous Organosilica Research Articles

A collagenase-decorated Cu-based nanotheranostics: remodeling extracellular matrix for optimizing cuproptosis and MRI in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC), characterized by a dense extracellular matrix (ECM), presents significant therapeutic challenges due to its poor prognosis and high resistance to chemotherapy. Current chemodrugs and diagnostic agents largely fail to cross the barrier posed by the ECM, which severely limits the PDAC theranostics. This study introduces a novel theranostic strategy using thioether-hybridized hollow mesoporous organosilica nanoparticles (dsMNs) for the co-delivery of copper (Cu) and disulfiram (DSF), aiming to induce cuproptosis in PDAC cells. Our approach leverages the ECM-degrading enzyme collagenase, integrated with dsMNs, to enhance drug penetration by reducing matrix stiffness. Furthermore, the innovative use of a pancreatic cancer cell membrane coating on the nanoparticles enhances tumor targeting and stability (dsMCu-D@M-Co). The multifunctional platform not only facilitates deep drug penetration and triggers cuproptosis effectively but also utilizes the inherent properties of Cu to serve as a T1-weighted magnetic resonance imaging (MRI) contrast agent. In vitro and in vivo assessments demonstrate significant tumor size reduction in PDAC-bearing mice, highlighting the dual functionality of our platform in improving therapeutic efficacy and diagnostic precision. This integrated strategy represents a significant advancement in the management of PDAC, offering a promising new direction for overcoming one of the most lethal cancers.Graphical

Overcoming therapeutic limitations in glioblastoma treatment: A nanocomposite inducing ferroptosis and oxeiptosis via Photodynamic therapy

Photodynamic therapy (PDT) is an effective treatment for glioblastoma (GBM) that activates photosensitizers to produce reactive oxygen species (ROS) while minimizing harm to normal tissues.However, the therapeutic outcomes of PDT are often unsatisfactory. This limitation arises partly from the challenges posed by the blood–brain barrier (BBB) in transporting photosensitizers and partly from the excessive levels of glutathione (GSH) in the tumor microenvironment (TME), which can neutralize ROS. Hypericin (HYP) has emerged as a promising photosensitizer for PDT due to its excellent photosensitizing properties and antitumor activity. Dysregulated iron metabolism is a hallmark of numerous cancers, including GBM. In this study, biodegradable tetra-sulfide-bound dendritic mesoporous organosilicas nanocomposite (NCs) modified with bovine serum albumin (BSA) were synthesized. NCs penetrates the BBB and selectively targets GBM by binding to secreted acidic protein acidic and rich in cysteine (SPARC), an albumin-binding receptor that is prominently expressed in both the BBB and GBM. Upon degradation in response to high GSH concentrations in the TME, the NCs release their payload while concurrently depleting GSH. Under laser irradiation, the ROS-generating agent HYP, loaded within the NCs, is combined with the ferroptosis inducer erastin to achieve a synergistic anti-GBM effect via PDT/ferroptosis. Additionally, the NCs induces oxeiptosis by regulating KEAP1/PGAM5/AIFM1 pathway. Consequently, NC inhibits GBM growth by inducing ferroptosis and oxeiptosis through excessive ROS production. This study demonstrates the potential of NCs to enhance the effectiveness of PDT, offering a promising therapeutic strategy for GBM patients.

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

The development of efficient photosensitizers is vital for advancing photodynamic therapy (PDT), a non-invasive cancer treatment. Although zinc phthalocyanine (ZnPc) has garnered significant attention as a photosensitizer in preclinical studies, its clinical application is hindered by poor solubility and a tendency to aggregate, despite its high absorption coefficient and low dark toxicity. To address these challenges, we developed a novel ZnPc-conjugated periodic mesoporous organosilica (PMO) nanoparticle, which enhances the photosensitizer's solubility, photostability, and biodegradability. The PMO nanoparticles retained the characteristic mesoporous structure, exhibited strong fluorescence emission, and effectively generated singlet oxygen. In vitro studies using 4T1 cells, along with in vivo experiments on a tumor-bearing mouse model, demonstrated that under 675nm laser irradiation, the ZnPc-PMO nanophotosensitizer induced reactive oxygen species, leading to significant inhibition of tumor growth. This ZnPc-bridged PMO nanophotosensitizer holds great promise for enhancing PDT efficacy and biocompatibility, offering a potential platform for multimodal phototherapeutic strategies.

Benzimidazole-based bimodal periodic mesoporous organosilica for thin film microextraction of triazole fungicides in fruiting vegetables prior to gas chromatography-mass spectrometry

Benzimidazole-based bimodal periodic mesoporous organosilica for thin film microextraction of triazole fungicides in fruiting vegetables prior to gas chromatography-mass spectrometry

Magnetic Triggering of Functional Organosilica Filler Particles for Controlling the Thermoreversible Attachment to Polymer Matrices.

Polymer materials containing filler particles are widely used in automotive components, construction materials, packaging materials, medical devices and supplies, and much more. The fillers strongly modulate the properties of the composite. In some applications, one is interested in smart features of those composites, meaning one can post-synthetically and reversibly change the characteristics as a response to an easy-to-apply trigger. For example, if the excision of an implant material may become necessary, then the polymer-filler hybrid changing from mechanically robust to soft(er) would be very beneficial. Here, we present a proof-of-concept study that shows that stimuli-responsive polymer-filler composites can be achieved by functional organosilica nanoparticles. The nanoparticles comprise a superparamagnetic core surrounded by a mesoporous organosilica shell. The polymer matrix is attached to the filler via Diels-Alder coupling to maleimide groups present at the surface of the organosilica. Exposure to an alternating magnetic field generates local heat in the organosilica particles. Utilizing fluorescence probes bound to the polymer backbone's side chains, we could prove that detachment occurs via a retro-Diels-Alder reaction within minutes.

Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis.

The management of inflammatory bowel disease (IBD) continues to pose significant challenges due to the absence of curative therapies and a high rate of recurrence. Therefore, it is imperative to explore novel approaches to enhance the efficacy of IBD therapy. Herein, a bioactive nanoparticulate s is tailored designed to achieve a "Pull-Push" approach for efficient and safe IBD treatment by integrating reactive oxygen species (ROS) scavenging (Pull) with anti-inflammatory agent delivery (Push) in the inflammatory microenvironment. The multifunctional nanomedicine, designated MON-PAMAM@SASP, is developed through the encapsulation of sulfasalazine (SASP), a widely utilized clinical drug for the treatment of IBD, within cationic diselenide-bridged mesoporous organosilica nanoparticles (MONs) that possess significant antioxidant properties. Herein, poly(amidoamine) (PAMAM) endows the original MONs with positive charge characteristics. The MON-PAMAM@SASP not only displays the remarkable capability of neutralizing ROS to ameliorates intestinal damage, but also achieves controllable release of SASP to mitigate intestinal inflammation. Consequently, this nanomedicine effectively mitigates IBD by colitis in mouse models, and our current research has not identified any significant drug toxicity. Beyond regulating inflammatory microenvironment in intestine, treatment with MON-PAMAM@SASP results in increased richness and restores intestinal microbiota homeostasis, thereby mitigating IBD to a certain extent. Together, our work provides a highly versatile "Pull-Push" approach for IBD management and encourages the development of similar nanomedicine to treating multiple inflammatory diseases of gastrointestinal tract.

Redox-responsive degradation of antimicrobials with programmable drug release for enhanced antibacterial activity

The global crisis of antibiotic resistance has impelled the exigency to develop more effective drug delivery systems for the treatment of bacterial infection. The development of possessing high biocompatibility and targeted delivery of antimicrobials remains a persisting challenge. For programmable release of efficient antimicrobials in infection sites to enhance antibacterial activity, herein, we fabricated diselenide-bridged mesoporous organosilica nanoparticle-supported silver nanoparticles (Ag NPs) with high drug-loading capacity for the co-delivery of tobramycin (TOB) within one drug delivery system (Ag-MON@TOB (Se)). The resultant Ag-MON@TOB (Se) exhibited favorable biocompatibility due to its high stability in the physiological condition. Notably, such Ag-MON@TOB (Se) manifested a programmable structural destabilization to trigger sequential drug release in response to the oxidative stimuli within the bacterial infection microenvironment. In contradistinction to the oxidation-stable disulfide bond moieties within the framework of the nanocarrier (Ag-MON@TOB (S)), the Ag-MON@TOB (Se) with its programmed drug release behavior augmented prominent antibacterial therapy both in vitro and in vivo. This work represents a promising strategy for programmable drug release by harnessing a responsive degradable vehicle to enhance the treatment of bacterial infection.

Biologically logic-gated Trojan-horse strategy for personalized triple-negative breast cancer precise therapy by selective ferroptosis and STING pathway provoking

Amidst the therapeutic quandaries associated with triple-negative breast cancer (TNBC), an aggressive malignancy distinguished by its immune resistance and limited treatment avenues, the urgent need for innovative solutions is underscored. To conquer the dilemma, we present a groundbreaking approach that ingeniously employs DNA-fragments-containing exosomes (DNA-Exo) and the concept of “biological logic-gates” to achieve precise homing and controlled selective activation of ferroptosis and stimulator interferon genes (STING) pathways. Leveraging insights from our previous research, a nano-Trojan-horse, Fe0@HMON@DNA-Exo, is engineered via in situ Fe0 synthesis within the glutathione (GSH)-responsiveness degradable hollow mesoporous organosilica nanoparticles (HMON) and subsequently enveloped in DNA-Exo derived from 7-ethyl-10-hydroxycamptothecin (SN38)-treated 4T1 cells. Emphasizing the precision of our approach, the DNA-Exo ensures specific ‘homing’ to TNBC cells, rendering a targeted delivery mechanism. Concurrently, the concept of “biological logic-gates” is employed to dictate a meticulous and selective activation of STING in antigen-presenting cells (APCs) under OR logic-gating with robust immune response and Fe0-based ferroptosis in TNBC cells under AND logic-gating with reactive oxygen species (ROS) storm generation. In essence, our strategy exhibits great potential in transforming the “immunologically cold” nature of TNBC, enabling precise control over cellular responses, illuminating a promising therapeutic paradigm that is comprehensive and productive in pursuing precision oncology and paving the way for personalized TNBC therapies.

Cobalt and nitrogen co-doped hollow periodic mesoporous organosilica spheres activated by potassium chloride for selective oxidation of ethylbenzene.

Enhancing the exposure of metal active sites and maximizing metal atom utilization are critical challenges in heterogeneous catalysis. To solve these issues, heterogeneous catalysts are usually activated by chemicals. Herein, potassium chloride (KCl) was used as an activator to prepare cobalt-nitrogen co-doped (Co-Nx) hollow periodic mesoporous organosilica spheres (Co-Nx/HPMOs-KCl). Co-Nx/HPMOs-KCl showed outstanding catalytic activity for the selective oxidation of ethylbenzene to acetophenone, with a conversion of up to 94.0% for ethylbenzene and a high selectivity of 98.4% towards acetophenone. Additionally, Co-Nx/HPMOs-KCl maintained excellent catalytic performance for the oxidation of ethylbenzene after six cycles. The excellent performance of Co-Nx/HPMOs-KCl was attributed to the activation of KCl, which increased the specific surface area of the catalyst and thus facilitated the exposure of more metal active sites. After the removal of unstable metal species through further acid treatment, the remaining metal active sites were thus fully exposed and stably embedded in the framework of the hollow periodic mesoporous organosilica spheres (HMPOs). This work presents an efficient catalyst and offers new insights for the improvement of heterogeneous catalysts.

Two Different Responsive Organosilica Nanocarriers to Combine Chemo- and Immunotherapy against Cancer.

The combination of chemo- and immunotherapy was recently demonstrated to improve a patient's response to therapy, giving rise to an emerging cancer treatment known as chemoimmunotherapy (CIT). Despite the promising benefits of CIT, the most important challenges are (i) the simultaneous or time-controlled delivery of two drugs and (ii) the selective uptake into different cells for each of the drugs: cancer cells for the chemotherapeutic and macrophages for the immunostimulation actives. Herein, a delivery strategy based on morphologically different stimuli-responsive breakable organosilica nanocarriers is exploited to transport two distinct drugs in the different cells using different times of delivery. We employ stimulus-sensitive, PEGylated organosilica nanocages to encapsulate the chemotherapeutic agent doxorubicin, which is preferentially taken up by tumor cells vs macrophages. On the other hand, similar size mesoporous organosilica nanoparticles, preferentially internalized by macrophages, are filled with the immunostimulator resiquimod. The administration in a sequential manner of the two different nanocarriers allowed us to assess the integrated effect of the combined therapy versus treatment with a single drug. In vitro work clearly shows an important reduction of tumor cell viability when both chemo- and immunotherapeutic agents are delivered.

Sustainable synthesis of benzimidazoles catalyzed by recyclable functionalized organosilica

A highly efficient protocol is herein reported for the preparation of benzimidazole compounds from o-phenylenediamine and various benzaldehyde derivatives in the presence of heterogeneous pyridinium protic ionic liquids supported on periodic mesoporous organosilica (PMO) in water. The synthesis of three novel benzimidazole derivatives is also reported. The proposed approach successfully afforded products in good yield under mild reaction conditions. PMO-Py-IL exhibited excellent catalyst activity and reusability for at least ten reaction cycles with no significant activity loss.

Novel Type of Non‐Toxic, Degradable, Luminescent Ratiometric Thermometers Based on Dyes Embedded in Disulfide‐Bridged Periodic Mesoporous Organosilica Particles

AbstractDespite the excellent thermometric performance of many developed luminescent nanomaterials, their use has not gone beyond proof‐of‐concept in vivo experiments to date. An important issue that needs to be resolved before moving toward true biomedical applications of engineered nanothermometers is their potential toxicity and bioaccumulation in the human body considering the ultimate objective of clinical applications. Since most reported nanothermometers currently are not degradable materials and are mainly based on the incorporation of heavy metal ions, these aspects remain of genuine concern in the fields of nanomedicine, nanobiotechnology, nanotoxicology, and nanopharmacology. This work explores the possibility of designing visible, as well as near‐infrared, emitting luminescent ratiometric nanothermometers based on appropriate organic dye mixtures embedded in hollow disulfide‐bridged periodic mesoporous organosilica (PMO) particles. Such hybrid particles show excellent thermometric performance in the physiological temperature range (20–50 °C), favorable degradability in simulated physiological conditions, as well as no toxicity to healthy normal human dermal fibroblast (NHDF) cells in a wide concentration range. Considering the simplicity of the approach from the synthetic point of view, and the large available library of known fluorescent dyes emitting in various regions of the electromagnetic range, this motif renders a very promising approach to designing novel non‐toxic, decomposable, luminescent ratiometric thermometers.

Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin B-loaded dendritic nanoparticles

Polymyxin B (PMB) is highly effective against Gram-negative bacterial infections, notably in targeting lipopolysaccharide (LPS), making it a vital last-resort treatment for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. However, its clinical application is hampered by nephrotoxicity and complications arising from its positive charge. This study introduces dendritic mesoporous organosilica nanoparticles loaded with PMB (PBSi-NPs), designed to overcome these limitations. The PBSi-NPs, with an average size of 170 nm, demonstrate effective LPS scavenging, enhanced bacterial internalization, and potent bactericidal properties. Their ability to release PMB in acidic microenvironments, characteristic of bacterial infections, significantly enhances the management of severe CRKP-induced infections. Notably, PBSi-NPs exhibit reduced toxicity towards human embryonic kidney cells (HEK 293), attributed to their stimulus-responsive design. In vivo, they exhibit higher targeting of lung cells than free PMB, specifically alveolar and bronchial cells, and effectively treat severe pneumonia in a CRKP (isolated from clinical sample) induced mouse model, markedly improving survival rates. This study proposes a novel, cost-effective method for PMB delivery using PBSi-NPs, potentially broadening the scope of nanomedicine for treating critically ill CRKP-infected patients.

Engineering optimal gold nanorod-loaded hollow mesoporous organosilica nanotheranostics for NIR-II photoacoustic microscopy imaging and tumor synergistic therapy

Biodegradable hollow mesoporous organosilica nanoparticles (HMON)-based nanotheranostics has recently gained growing interests due to their tremendous potential as an attractive platform for cancer imaging and therapy. However, the engineering of HMON-based nanotheranostics for size-dependent biological profile on in vivo tumor uptake, biodistribution and retention in tumor region have not been achieved to date. Here, a novel tumor microenvironment (TME)-activated nanoplatform employing miniature gold nanorod-loaded HMON (Au@HMON) with tunable hollow cavity of HMON coating is presented, and its application in the second near infrared (NIR-II, 1000–1700 nm) window photoacoustic microscopy (PAM) imaging-guided synergistic chemo-photothermal therapy is studied by loading doxorubicin (DOX). The cancer cell membrane (CCM) biomimetic nanotheranostics (Au@HMON-DOX@CCM) exhibited a high photothermal conversion efficiency of 41.1 % for photothermal therapy (PTT) and PAM imaging. Among the three investigated nanotheranostics, the 221 nm-nanotheranostics exhibited stronger PAM signal and higher drug loading efficacy than the small counterparts (156- and 186-nm) due to the thicker HMON coating layer, larger surface area and intermediate void structure. Therefore, synergistic chemo-photothermal therapy using 221 nm-nanotheranostics is achieved to efficiently inhibit tumor growth. This strategy affords design parameters for engineering HMON-based “all-in-one” nanotheranostics for photoacoustic imaging-guided cancer treatment.

Glutathione-responsive biodegradable nanohybrid for cancer photoacoustic imaging and gas-assisted photothermal therapy

Photothermal therapy (PTT), particularly in the near-infrared-II (NIR-II) range, has attracted widespread attention over the past years. However, the accompanied inflammatory responses can result in undesirable side effects and contribute to treatment ineffectiveness. Herein, we introduced a novel biodegradable nanoplatform (CuS/HMON-PEG) capable of PTT and hydrogen sulfide (H2S) generation, aimed at modulating inflammation for improved cancer treatment outcomes. The embedded ultrasmall copper sulphide (CuS) nanodots (1–2 nm) possessed favorable photoacoustic imaging (PAI) and NIR-II photothermal capabilities, rendering CuS/HMON-PEG an ideal phototheranostic agent. Upon internalization by 4T1 cancer cells, the hollow mesoporous organosilica nanoparticle (HMON) component could react with the overproduced glutathione (GSH) to produce H2S. In addition to the anticipated photothermal tumor ablation and H2S-induced mitochondrial dysfunction, the anti-inflammatory regulation was also been demonstrated by the downregulation of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1beta (IL-1β). More importantly, the modulation of inflammation also promoted wound healing mediated by PTT. This work not only presents a H2S-based nanomodulator to boost NIR-II PTT but also provides insights into the construction of novel organic/inorganic hybrid nanosystems.

Revolutionizing protein hydrolysis in wastewater: Innovative immobilization of metagenome-derived protease in periodic mesoporous organosilica with imidazolium framework

This research focused on utilizing periodic mesoporous organosilica with imidazolium framework (PMO-IL), to immobilize a metagenome-sourced protease (PersiProtease1), thereby enhancing its functional efficiency and catalytic effectiveness in processing primary proteins found in tannery wastewater. The successful immobilization of enzyme was confirmed through the use of N2 adsorption-desorption experiment, XRD, FTIR, TEM, FESEM, EDS and elemental analytical techniques. The immobilized enzyme exhibited greater stability in the presence of various metal ions and inhibitors compared to its free form. Furthermore, enzyme binding to PMO-IL nanoparticles (NPs) reduced leaching, evidenced by only 11.41 % of enzyme leakage following a 120-min incubation at 80 °C and 6.99 % after 240 min at 25 °C. Additionally, PersiPro@PMO-IL maintained impressive operational consistency, preserving 62.24 % of its activity over 20 cycles. It also demonstrated notable stability under saline conditions, with an increase of 1.5 times compared to the free enzyme in the presence of 5 M NaCl. The rate of collagen hydrolysis by the immobilized protease was 46.82 % after a 15-minute incubation at 60 °C and marginally decreased to 39.02 % after 20 cycles indicative of sustained efficacy without significant leaching throughout the cycles. These findings underscore the effectiveness of PMO-IL NPs as a viable candidate for treating wastewater containing protein.

Facile synthesis of copper sulfide loaded mesoporous organosilica nanospheres with a triple-shelled hollow structure

Facile synthesis of copper sulfide loaded mesoporous organosilica nanospheres with a triple-shelled hollow structure

A near-infrared light-driven Janus nanomotor for deep tumor penetration and enhanced tumor immunotherapy.

A near-infrared light-driven Janus nanomotor is constructed by collagenase-coated gold nanorods and chitosan-functionalized mesoporous organosilica nanoparticles with Mn2+ as the bridging ion. The nanomotors with excellent motility and collagenase activity can potently penetrate into tumors to sufficiently activate innate immune responses, significantly enhancing anti-tumor immune efficacy in vivo.

A hollow mesoporous iron oxide nanoparticle to strengthen Fenton reaction and weaken antioxidant defense systems for high efficacy tumor ferroptosis therapy

Traditional drug delivery system (DDS) such as hollow mesoporous organosilica nanoparticle (HMON) can achieve efficient delivery of ferroptosis-inducing agents for tumor therapy due to its high drug loading content (DLC), but is limited by their slow degradation and the uselessness of their silicon-based compounds. In this study, a novel hollow mesoporous superparamagnetic iron oxide nanoparticle (HMSPION) was developed with 100 nm of hollow core and 40 nm of mesoporous shell with a high DLC (up to 22.9 %) of β-Lapachone (LAP), doxorubicin (DOX), sorafenib (SFN) and/or Zn2+. Furthermore, we propose a new strategy to strengthen Fenton reaction and weaken antioxidant defense systems in tumors by co-loading Zn2+ and LAP into HMSPION to generate LAP@HMSPION@Zn. Specifically, i) LAP@HMSPION@Zn is degraded into Fe2+/3+, Zn2+, and LAP in acidic tumor microenvironment. ii) LAP catalyzes O2 to be superoxide anion radical (O2•−) and Zn2+ raises the O2•− production in mitochondria. iii) The O2•− can be catalyzed into hydrogen peroxide (H2O2) via superoxide dismutase. iv) H2O2 and the released Fe2+ accelerate the Fenton reaction, generating highly toxic hydroxyl radical (•OH). v) The Fe3+ consumes GSH and LAP downregulates GSH level by NADPH consumption, thereby relieving the antioxidant defense systems in tumor cells.

Highly ordered Periodic Mesoporous Organosilica material containing the ionic 4,4-bipyridinium group and decorated with palladium nanoparticles: A proposal for nanoreactor

A Periodic Mesoporous Organosilica (PMO) containing the cationic 4,4-bipyridinium group, presenting 0.25 mmol g−1 that corresponds to 11.5 w/w%, was successfully prepared. This material was designed to have the ionic group acting as anchoring agent of PdCl42- anion complex, in a much lower amount than the available cationic sites (3 and 15 molar%). Subsequently, the palladium complex was in situ reduced to obtain stabilized palladium nanoparticles (PdNP). The ensemble of characterization results showed that the PMO material walls have a cylindrical morphology with hexagonal packing, generating well-ordered pores with a narrow size distribution and high surface area, even after being decorated with PdNP. This material is a candidate to be an efficient nanoreactor considering that it contains spatial uniformity in its chemical sites and confined environment. Aiming to evaluate the availability of palladium sites, the material was used as a catalyst in the reduction of p-nitrophenol model reaction. Although the catalyst of the present study has a comparable activity with other already reported systems, it presents the impressive lowest molar palladium/p-nitrophenol ratio found in literature.